Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HemOx Transfusion Study
NCT07677150Not yet recruiting
- Sponsor
- Medical University of Innsbruck
- Start
- Oct 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Randomised trial (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Half pressure of hemoglobin oxygen saturation. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07677150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677150.